157 related articles for article (PubMed ID: 7966797)
1. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
Chen J; Godschalk M; Katz PG; Mulligan T
J Urol; 1995 Jan; 153(1):80-1. PubMed ID: 7966797
[TBL] [Abstract][Full Text] [Related]
2. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
3. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
4. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
Tang SF; Chu NK; Wong MK
Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
[TBL] [Abstract][Full Text] [Related]
5. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
Mattarelli G; Leibundgut B
Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
[TBL] [Abstract][Full Text] [Related]
6. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
[TBL] [Abstract][Full Text] [Related]
7. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
[TBL] [Abstract][Full Text] [Related]
8. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
Schrey A
Fortschr Med; 1990 Oct; 108(30):577-80. PubMed ID: 2245960
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
[TBL] [Abstract][Full Text] [Related]
10. A prostaglandin E1 dose-response study in man.
von Heyden B; Donatucci CF; Marshall GA; Brock GB; Lue TF
J Urol; 1993 Dec; 150(6):1825-8. PubMed ID: 8230515
[TBL] [Abstract][Full Text] [Related]
11. An attempt to standardize the pharmacological diagnostic screening of vasculogenic impotence with prostaglandin E1.
McMahon CG
Int J Impot Res; 1995 Jun; 7(2):83-90. PubMed ID: 7496445
[TBL] [Abstract][Full Text] [Related]
12. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
14. [Prostaglandin treatment in neurological patients with erectile dysfunction].
Conejero Sugrañes J; Muñoz Villellas A; Sarrias Lorenz F; Ramírez Garceran L
Arch Esp Urol; 2002; 55(1):63-8. PubMed ID: 11957754
[TBL] [Abstract][Full Text] [Related]
15. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
[TBL] [Abstract][Full Text] [Related]
16. Slow injection of prostaglandin E1 decreases associated penile pain.
Gheorghiu D; Godschalk M; Gheorghiu S; Mulligan T
Urology; 1996 Jun; 47(6):903-4. PubMed ID: 8677586
[TBL] [Abstract][Full Text] [Related]
17. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
Beretta G; Zanollo A; Portalupi W
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
[TBL] [Abstract][Full Text] [Related]
18. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
Chen RN; Lakin MM; Montague DK; Ausmundson S
J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
[TBL] [Abstract][Full Text] [Related]
19. Cavernous auto-injection therapy with prostaglandin E1.
Nisén H
Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
[TBL] [Abstract][Full Text] [Related]
20. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]